Investment analysts at KeyCorp initiated coverage on shares of Olin (NYSE:OLN – Get Free Report) in a report released on Friday, Marketbeat reports. The brokerage set an “overweight” rating and a $26.00 price target on the specialty chemicals company’s stock. KeyCorp’s target price points to a potential upside of 50.51% from the stock’s previous close. KeyCorp also issued estimates for Olin’s Q3 2026 earnings at $0.06 EPS, Q4 2026 earnings at ($0.20) EPS and FY2028 earnings at $1.35 EPS.
Several other research firms have also recently issued reports on OLN. Mizuho boosted their target price on Olin from $23.00 to $24.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $20.00 price target (down from $25.00) on shares of Olin in a research note on Monday, August 3rd. The Goldman Sachs Group decreased their price objective on shares of Olin from $24.00 to $20.00 and set a “neutral” rating on the stock in a report on Tuesday, August 4th. BMO Capital Markets reduced their price target on shares of Olin from $30.00 to $25.00 and set a “market perform” rating for the company in a research report on Monday, July 6th. Finally, Bank of America cut Olin from a “buy” rating to an “underperform” rating and lowered their price target for the stock from $32.00 to $21.00 in a report on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, ten have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Olin has a consensus rating of “Reduce” and an average target price of $22.62.
Olin Stock Performance
Olin (NYSE:OLN – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The specialty chemicals company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.25). Olin had a negative net margin of 2.08% and a negative return on equity of 4.76%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the prior year, the firm posted ($0.01) earnings per share. The company’s revenue for the quarter was down .9% compared to the same quarter last year. As a group, equities analysts forecast that Olin will post -0.68 earnings per share for the current year.
Institutional Investors Weigh In On Olin
Hedge funds have recently modified their holdings of the company. Orbis Allan Gray Ltd lifted its stake in shares of Olin by 448.9% during the 4th quarter. Orbis Allan Gray Ltd now owns 3,804,561 shares of the specialty chemicals company’s stock worth $79,249,000 after purchasing an additional 3,111,393 shares during the period. California State Teachers Retirement System grew its position in shares of Olin by 1,831.5% in the second quarter. California State Teachers Retirement System now owns 2,599,373 shares of the specialty chemicals company’s stock valued at $51,520,000 after purchasing an additional 2,464,794 shares during the period. Millennium Management LLC grew its position in shares of Olin by 1,063.0% in the third quarter. Millennium Management LLC now owns 2,486,702 shares of the specialty chemicals company’s stock valued at $62,143,000 after purchasing an additional 2,272,877 shares during the period. Bank of New York Mellon Corp acquired a new position in Olin in the second quarter valued at $23,785,000. Finally, Semper Augustus Investments Group LLC lifted its position in Olin by 141.3% during the third quarter. Semper Augustus Investments Group LLC now owns 1,924,245 shares of the specialty chemicals company’s stock worth $48,087,000 after buying an additional 1,126,809 shares during the period. 88.67% of the stock is owned by institutional investors and hedge funds.
Olin Company Profile
Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
Further Reading
- Five stocks we like better than Olin
- Chime Finds Its Stride With a $590M Deal That Could Reshape Its Banking Model
- IBM and Lockheed Martin Turn a Swiss Defense Deal Into a Quantum Computing Bet
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
